Menu
Back to User profile » Dr Cecilia Lazea
Papers published by Dr Cecilia Lazea:
PFAPA Syndrome: Clinical, Laboratory and Therapeutic Features in a Single-Centre Cohort
Lazea C, Damian L, Vulturar R, Lazar C
International Journal of General Medicine 2022, 15:6871-6880
Published Date: 29 August 2022
Diagnosis and Management of Genetic Causes of Middle Aortic Syndrome in Children: A Comprehensive Literature Review
Lazea C, Al-Khzouz C, Sufana C, Miclea D, Asavoaie C, Filimon I, Fufezan O
Therapeutics and Clinical Risk Management 2022, 18:233-248
Published Date: 16 March 2022
Diagnostic Usefulness of MLPA Techniques for Recurrent Copy Number Variants Detection in Global Developmental Delay/Intellectual Disability
Miclea D, Szucs A, Mirea AM, Stefan DM, Nazarie F, Bucerzan S, Lazea C, Grama A, Pop TL, Farcas M, Zaharie G, Matyas M, Mager Snr M, Vintan M, Popp R, Alkhzouz C
International Journal of General Medicine 2021, 14:4511-4515
Published Date: 16 August 2021
Skeletal Abnormalities and VDR1 Gene Polymorphisms in Mucopolysaccharidosis Patients
Alkhzouz C, Cabau G, Lazea C, Asavoaie C, Bucerzan S, Mirea AM, Farcas M, Miclaus M Jnr, Popp R, Miclea D
Pharmacogenomics and Personalized Medicine 2021, 14:349-358
Published Date: 17 March 2021
ROHHAD (Rapid-onset Obesity with Hypoventilation, Hypothalamic Dysfunction, Autonomic Dysregulation) Syndrome—What Every Pediatrician Should Know About the Etiopathogenesis, Diagnosis and Treatment: A Review
Lazea C, Sur L, Florea M
International Journal of General Medicine 2021, 14:319-326
Published Date: 29 January 2021
Unusual Presentation Of Kawasaki Disease With Gastrointestinal And Renal Manifestations
Lazea C, Man O, Sur LM, Serban R, Lazar C
Therapeutics and Clinical Risk Management 2019, 15:1411-1416
Published Date: 5 December 2019
Rare complications of neurofibromatosis 1 diagnosed incidentally in two children
Lazea C, Asavoaie C, Al-Khzouz C, Popa L
Therapeutics and Clinical Risk Management 2018, 14:1547-1552
Published Date: 31 August 2018
Clinical and genetic characteristics in a group of 45 patients with Turner syndrome (monocentric study)
Bucerzan S, Miclea D, Popp R, Alkhzouz C, Lazea C, Pop IV, Grigorescu-Sido P
Therapeutics and Clinical Risk Management 2017, 13:613-622
Published Date: 4 May 2017